Fluorescent Light Energy: Treating Rosacea Subtypes 1, 2, and 3
Clinical case reports(2018)
Abstract
Kleresca® biophotonic platform utilizing fluorescent light energy effectively decreased the inflammatory and erythematous reaction common in rosacea subtypes 1, 2, and 3. Kleresca® may be considered as a single treatment for rosacea, targeting multiple features, or combined with invasive methods for an enhanced normalizing and healing profile of the skin.
MoreTranslated text
Key words
biophotonic platform,chromophore,erythema,fluorescent light energy,inflammation,rosacea,subtype 1, 2, and 3
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined